Search Results - "Gee, A P"

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients by MEHTA, J, SINGHAL, S, GEE, A. P, CHIANG, K-Y, GODDER, K, VAN RHEE, F, DERIENZO, S, O'NEAL, W, LAMB, L, HENSLEE-DOWNEY, P. J

“…Between February 1993 and December 1999, 201 patients (1-59 years old, median 23) with acute leukemia (67% not in remission) underwent ex vivo T-cell-depleted…”
Get full text

Manufacturing genetically modified T cells for clinical trials by Gee, A P

“…Compliance with Food and Drug Administration regulations relating to initiating early phase clinical trials of new cellular therapy products often presents a…”
Get full text

Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience by Anderlini, P., Donato, M., Chan, K.-W., Huh, Y.O., Gee, A.P., Lauppe, M.J., Champlin, R.E., Körbling, M.

“…BACKGROUND: Information on the safety and efficacy of allogeneic peripheral blood progenitor cell (PBPC) collection in filgrastim‐mobilized normal donors is…”
Get full text

A multicenter comparison study between the Endosafe® PTS™ rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products by Gee, A.P., MI Biol, PhD, Sumstad, D, Stanson, J, Watson, P, Proctor, J, Kadidlo, D, Koch, E, Sprague, J, Wood, D, Styers, D, McKenna, D, Gallelli, J, Griffin, D, Read, E.J, Parish, B, Lindblad, R

“…Background Rapid-release testing reduces the waiting period for administration of time-sensitive cell-therapy products. Current assay systems are labor…”
Get full text

T-Cell Immunotherapy for Adenoviral Infections of Stem-Cell Transplant Recipients by LEEN, A. M., MYERS, G. D., BOLLARD, C. M., HULS, M. H., SILI, U., GEE, A. P., HESLOP, H. E., ROONEY, C. M.

“…: Human adenoviruses are ubiquitous lytic DNA viruses that can be divided into 51 different serotypes, grouped from A to F on the basis of genome size,…”
Get full text

Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors by LAMB, L. S, GEE, A. P, HARRIS, W. G, PARRISH, R. S, HENSLEE-DOWNEY, P. J, GEIER, S. S, HAZLETT, L, PATI, A. R, GODDER, K, ABHYANKAR, S. A, TURNER, M. W, LEE, C

“…Myeloablative chemotherapy followed by transplantation of a T cell-depleted bone marrow graft from a partially mismatched related donor provides a potentially…”
Get full text

Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility by Grilley, B.J., Gee, A.P.

“…The first human gene-transfer study was submitted to the Recombinant DNA Advisory Committee (RAC) in 1988, thus initiating a new era in clinical research. As…”
Get full text

What a cell-processing laboratory can and can't do for cellular therapy by Gee, A.P.

Get full text

Partially Mismatched Related-Donor Bone Marrow Transplantation for Pediatric Patients With Acute Leukemia: Younger Donors and Absence of Peripheral Blasts Improve Outcome by GODDER, K. T, HAZLETT, L. J, PATI, A. R, PARRISH, R. S, HENSLEE-DOWNEY, P. J, ABHYANKAR, S. H, CHIANG, K. Y, CHRISTIANSEN, N. P, BRIDGES, K. D, LEE, C. G, GEIER, S. S, GOON-JOHNSON, K. S, GEE, A. P

“…To extend access to bone marrow transplantation (BMT), we used partially mismatched related donors (PMRD) for pediatric patients with acute leukemia. In this…”
Get full text

Cell sorting for therapeutic applications — points to consider by Gee, A.P., Durett, A.G.

Get full text

Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo by Boyle, MD, Lawman, MJ, Gee, AP, Young, M

“…Previous studies have shown that mouse submandibular gland nerve growth factor (NGF) stimulates chemotactic migration of human polymorphonuclear leukocytes in…”
Get full text

Product release assays by Gee, A.P.

Get full text

Donor leukocyte infusion for treatment of graft rejection post partially mismatched related donor bone marrow transplant by GODDER, K. T, ABHYANKAR, S. H, LAMB, L. S, BEST, R. G, GEIER, S. S, PATI, A. R, GEE, A. P, HENSLEE-DOWNEY, P. J

“…Graft rejection following bone marrow transplantation is more common in patients who receive their grafts from alternative donors and whose marrow is T cell…”
Get full text

Flow cytometric cell sorting combined with molecular chimerism analysis to detect minimal recurrent leukemia: good news and bad news by LAMB, L. S, ROBBINS, N. F, ABHYANKAR, S, JOYCE, M, STETLER-STEVENSON, M, HENSLEE-DOWNEY, P. J, GEE, A. P

“…Allogeneic BMT offers the possibility of cure for a variety of hematopoietic malignancies, but disease relapse remains a major cause of treatment failure. This…”
Get full text

Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma by Pati, A R, Godder, K T, Abhyankar, S H, Gee, A P, Henslee-Downey, P J

“…Eight consecutive patients with relapsed/refractory non-Hodgkin's lymphoma or Hodgkin's disease received conditioning therapy with BCNU, etoposide, cytosine…”
Get more information

Partially mismatched related donor transplants as salvage therapy for patients with refractory leukemia who relapse post-BMT by Godder, K, Pati, A, Abhyankar, S, Gee, A P, Parrish, R, Lee, C, Henslee-Downey, P J

“…Patients who relapse post-ABMT are usually resistant to conventional therapy, and a potentially curative therapy with allogeneic BMT is limited due to…”
Get more information

Are you feeling ablated? by Gee, A.P.

Get full text

Acute rejection of marrow grafts in patients transplanted from a partially mismatched related donor: clinical and immunologic characteristics by Lamb, Jr, L S, Gee, A P, Parrish, R S, Lee, C, Walker, M, Geier, S, Harris, G, Pati, A, Godder, K, Henslee-Downey, P J

“…Bone marrow transplantation (BMT) from a partially mismatched related donor (PMRD) provides a treatment option for patients lacking a matched sibling donor. T…”
Get more information

Immune therapy for EBV infections after hemopoietic stem-cell transplant by Heslop, H.E., Bollard, C.M., Gottschalk, S., Kuehnle, I., Huls, M.H., Gee, A.P., Brenner, M.K., Rooney, C.M.

Get full text

ISHAGE committees--the whole is, indeed, and in deed, greater than the sum of its parts by Collins, N H, Gee, A P

Get full text